Synthesis, Characterization and Antiproliferative Activity Test of Some Diphenyltin(IV) Hydroxybenzoates Against A549, MCF-7 and HeLa Human Cancer Cell Lines

Sutopo Hadi,Ermin K. Winarno,Hendig Winarno,Susanto Susanto,Dea A. S. Thian,Muhammad D. Fansang,Khairun N. Berawi,Tati Suhartati
DOI: https://doi.org/10.1007/s10904-024-03042-2
IF: 3.518
2024-04-17
Journal of Inorganic and Organometallic Polymers and Materials
Abstract:Due to the various side effects of conventional cancer treatment therapy, efforts to find anticancer agents with minimal side effects are in great demand. One of them is the synthesis of organotin(IV) hydroxybenzoate derivatives. Three organotin(IV) compounds, namely diphenyltin(IV) 2-hydroxybenzoate, [Ph 2 Sn(2-HBz) 2 ] (DPT2-DH) ( 2 ), diphenyltin(IV) 3-hydroxybenzoate, [Ph 2 Sn(3-HBz) 2 ] (DPT3-DH) ( 3 ) and diphenyltin(IV) 4-hydroxybenzoate, [Ph 2 Sn(4-HBz) 2 ] (DPT4-DH) ( 4 ), have been successfully synthesized. Compounds 2 – 4 were obtained by reacting diphenyltin(IV) oxide, [Ph 2 SnO] (DPTO) ( 1 ) with 2-hydroxybenzoic acid (2-HHBz), 3-hydroxybenzoic acid (3-HHBz) and 4-hydroxybenzoic acid (4-HHBz), respectively. The compounds synthesized were fully characterized by UV–Vis, FT-IR, and NMR spectroscopies and microelemental analysis to see the purity of the compounds. The antiproliferative activity of the compounds was tested against three cancer cell lines of lung cancer (A549), breast cancer (MCF-7) and cervical cancer (HeLa), and their activities were compared to normal cell cancer, Vero. The results of the antiproliferative test demonstrated that compound 2 was found to be most active against the A549 cell line. Compounds 2 and 3 are active against MCF-7 while compound 4 was found to be least active against all cancer lines tested. All compounds have also been found to have a good selectivity index (SI) toward the A549 cell line, although their SI values are not good enough against the HeLa cell line.
polymer science
What problem does this paper attempt to address?